Biomed cures its funding problem
13th Nov 2006, 23:31 GMT
MANY biomedical start-ups often have difficulty getting equity funding. Investors tend to shy away from such companies whose research products typically take a long time to develop and, as such, it may sometimes take years before rewards are reaped.
Biomed cures its funding problem related news:
- Lourdes cures 'not miracles' — BBC News Player | World
- Toronto's Shaftsbury takes 'Cures' — Variety.com
- Rwanda: Corruption Hampering Success of APRM — AllAfrica News: Central Africa Business
- Commission wants funding for Pa. transportation — Latest news from Philadelphia Business Journal
- Single-Dose Drug-Loaded Dendrimer Cures Mice of Colon Cancer — PhysOrg.com - latest science and technology news
- Apartheid in Reverse — Ohmynews International
- Intransa closes new funding round — bizjournals.com Banking & Financial Services:Venture Capital headlines
- Buyout funding wait for islanders — BBC News | UK News | Scotland | World Edition
- San Jose's A10 gets $9M in new funding — Latest news from Silicon Valley/San Jose Business Journal
- Federal funding aims at boosting transit security — CTV Canada